Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue plasminogen activator: hospital experience.

G LiMandri1, D Dunn, C Burd

  • 1Cardiopulmonary Department, Overlook Hospital, Summit, NJ 07901.

New Jersey Medicine : the Journal of the Medical Society of New Jersey
|August 1, 1991
PubMed
Summary

Tissue plasminogen activator (t-PA) effectively treats acute myocardial infarction (MI) with a low complication rate. This study in 74 patients demonstrated acceptable patency and good outcomes for t-PA in MI treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toceranib phosphate resolves right heart obstruction secondary to a heart base neoplasm in a dog.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2022
Same author

MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?

European radiology·2021
Same author

Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.

HIV medicine·2020
Same author

Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self-testing trial.

HIV medicine·2020
Same author

Individuals with high bone mass have increased progression of radiographic and clinical features of knee osteoarthritis.

Osteoarthritis and cartilage·2020
Same author

Subregional statistical shape modelling identifies lesser trochanter size as a possible risk factor for radiographic hip osteoarthritis, a cross-sectional analysis from the Osteoporotic Fractures in Men Study.

Osteoarthritis and cartilage·2020

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Acute myocardial infarction (MI) is a leading cause of mortality.
  • Timely reperfusion therapy is critical for improving outcomes in MI patients.
  • Tissue plasminogen activator (t-PA) is a key thrombolytic agent used in MI treatment.

Purpose of the Study:

  • To evaluate the safety and efficacy of t-PA in patients with acute MI.
  • To assess complication rates, patency rates, and patient outcomes following t-PA administration.

Main Methods:

  • A study involving 74 patients diagnosed with acute MI.
  • Administration of t-PA as a treatment for acute MI.
  • Monitoring of complication rates, arterial patency, and clinical outcomes.

Main Results:

Related Experiment Videos

  • t-PA was administered safely and efficiently in the studied patient cohort.
  • A low rate of complications was observed.
  • Acceptable patency rates and good patient outcomes were achieved.

Conclusions:

  • t-PA is a safe and effective treatment option for acute myocardial infarction.
  • The study supports the use of t-PA in clinical practice for acute MI, given its favorable safety and efficacy profile.